| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/1994 | US5284869 Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty |
| 02/08/1994 | US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer |
| 02/08/1994 | US5284867 (3S,4S)-Tetrahydrocannabinol treatment of nervous system disorders |
| 02/08/1994 | US5284861 Blended with deprenyl and biperiden; muscle relaxant |
| 02/08/1994 | US5284859 Analgesics, Alzheimer's disease |
| 02/08/1994 | US5284857 Substituted thienopyrans as antihypertensive agents |
| 02/08/1994 | US5284855 7-(2,7-diazabicyclo[3.3.0]octyl)-3-quinolone-and-naphthyridonecarboxylic acid derivatives |
| 02/08/1994 | US5284849 Renin inhibitors |
| 02/08/1994 | US5284847 Neurological and psychological disorders; antagonist at the glycine binding site on the N-methyl-D-aspartate receptor complex |
| 02/08/1994 | US5284845 Use of oral diazoxide for the treatment of disorders in glucose metabolism |
| 02/08/1994 | US5284843 Pharmacological treatment of ocular development |
| 02/08/1994 | US5284841 Benzo-fused lactams promote release of growth hormone |
| 02/08/1994 | US5284839 Neuropeptide antagonist; renal and cerebral areas included |
| 02/08/1994 | US5284836 Heterocyclic phospholipids useful in treating multiple sclerosis |
| 02/08/1994 | US5284835 Use of dilinoleoylphosphatidylcholine (DLPC) for treatment and prevention of cirrhosis and fibrosis in the liver |
| 02/08/1994 | US5284831 Boron neutron capture therapy |
| 02/08/1994 | US5284662 Core of carbamazepine, crystal habit modifiers, hydroxyalkyl c celluloses, sugar alcohol, and mono- or disacdaride, semipermeable wall and hole in wall |
| 02/08/1994 | US5284651 Oxidation of polyvalent phenols in aqueous alkaline media at controlled temperature yields nontoxic, nonmutagenic, nonteratogenic humic acid derivatives |
| 02/08/1994 | US5284645 Stable, biocompatible |
| 02/08/1994 | CA1326853C Ethynylheteroaromatic acids having retinoic acid-like activity |
| 02/08/1994 | CA1326851C Oxadiazolyl-1,4-dihydropyridines and the analogues thereof |
| 02/08/1994 | CA1326849C Treatment of malignant tumors with 8 chloroadenosine 3',5'-cyclic phosphate, and preparation thereof |
| 02/08/1994 | CA1326848C 5-substituted uridine derivatives and intermediates for preparation thereof |
| 02/07/1994 | CA2101901A1 Therapeutic heterocyclic derivatives |
| 02/07/1994 | CA2075421A1 Pharmaceutical preparation of antihypertensive, antianginal , antiarrhythmic and antiglaucomic action |
| 02/06/1994 | CA2103655A1 Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present |
| 02/06/1994 | CA2101915A1 Tetrahydronaphthalene derivatives, their preparation and their application in therapy |
| 02/06/1994 | CA2101789A1 Process for the preparation of imidazopyridines |
| 02/06/1994 | CA2101680A1 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| 02/05/1994 | CA2092218A1 Process for the preparation of glycine-conjugated bile acids and relative pharmaceutical compositions useful for treating hepatic insufficiency |
| 02/04/1994 | CA2101357A1 Veterinary method |
| 02/04/1994 | CA2101234A1 Anti-urease cosmetic or dermatological composition |
| 02/04/1994 | CA2101230A1 Derivatives of quinic acid and a process for their production |
| 02/03/1994 | WO1994002637A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |
| 02/03/1994 | WO1994002623A1 Blood levels of cck peptides relative to panic disorder treatment |
| 02/03/1994 | WO1994002595A1 Method and reagent for treatment of animal diseases |
| 02/03/1994 | WO1994002586A2 Repression of virulent gene expression |
| 02/03/1994 | WO1994002518A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 02/03/1994 | WO1994002501A1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 02/03/1994 | WO1994002499A1 Oligonucleotide alkylphosphonothioates |
| 02/03/1994 | WO1994002498A1 Hybrid oligonucleotide phosphorothioates |
| 02/03/1994 | WO1994002496A1 Derivatives of 16-membered ring antibiotic macrolides |
| 02/03/1994 | WO1994002495A1 Esterification process |
| 02/03/1994 | WO1994002493A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 02/03/1994 | WO1994002492A1 Novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds |
| 02/03/1994 | WO1994002489A1 Cephalosporins and 1-carba-1-dethia cephalosporins |
| 02/03/1994 | WO1994002488A1 BIS-STAUROSPORINE AND K-252a DERIVATIVES |
| 02/03/1994 | WO1994002487A1 Novel pyridonecarboxylic acid derivatives and processes for preparing the same |
| 02/03/1994 | WO1994002485A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002484A1 Family of porphin ring substances, method of obtaining them from cyanophyceae, and applications as cosmetics and as therapeutic products |
| 02/03/1994 | WO1994002483A1 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents |
| 02/03/1994 | WO1994002482A1 1-azaadamantane derivatives as 5-ht agonists or antagonists |
| 02/03/1994 | WO1994002480A1 Quinoline and naphthyridine prodrugs |
| 02/03/1994 | WO1994002479A1 Novel diazabicycloalkenes and processes for the preparation thereof |
| 02/03/1994 | WO1994002478A1 (hetero)-aryl ketones derivatives with antibacterial properties |
| 02/03/1994 | WO1994002477A1 Imidazole, triazole and tetrazole derivatives |
| 02/03/1994 | WO1994002475A1 Drugs that enhance synaptic responses mediated by ampa receptors |
| 02/03/1994 | WO1994002474A1 Endothelin receptor antagonists |
| 02/03/1994 | WO1994002473A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them |
| 02/03/1994 | WO1994002470A1 Pesticidal pyrimidine compounds |
| 02/03/1994 | WO1994002469A1 Pyrimidine compounds used in the therapy |
| 02/03/1994 | WO1994002465A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF |
| 02/03/1994 | WO1994002464A1 New pyridine derivatives as leukcotriene b4 antagonists |
| 02/03/1994 | WO1994002463A1 Antihypertensive 1,4-dihydropyridine derivatives and process for their preparation |
| 02/03/1994 | WO1994002462A1 4-amino-n^_-(4-methyl-4-piperidinyl)-2-methoxybenzamides |
| 02/03/1994 | WO1994002461A1 Azacyclic compounds |
| 02/03/1994 | WO1994002460A1 Indol derivatives for the treatment of migraine |
| 02/03/1994 | WO1994002459A1 Indolinyl n-hydrozyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
| 02/03/1994 | WO1994002453A1 Ng-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock |
| 02/03/1994 | WO1994002450A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 02/03/1994 | WO1994002448A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002445A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression |
| 02/03/1994 | WO1994002442A1 PHARMACOLOGICALLY ACTIVE α-[TERTIARY-AMINOMETHYL]-BENZENEMETHANOL DERIVATIVES |
| 02/03/1994 | WO1994002199A1 Treatment of physiological conditions with degassed perfluorocarbon liquid |
| 02/03/1994 | WO1994002182A1 A two component fibrin-glue composition for improving in vitro fertilization |
| 02/03/1994 | WO1994002177A1 Method of preparation of inclusion compounds of nimesulide with cyclodextrins |
| 02/03/1994 | WO1994002168A1 Novel medicinal composition |
| 02/03/1994 | WO1994002166A1 Nutritional product for persons having a neurological injury |
| 02/03/1994 | WO1994002155A1 Antiviral combinations |
| 02/03/1994 | WO1994002154A1 Antiviral combinations |
| 02/03/1994 | WO1994002153A1 Use of sulphur containing phospholipids for treating leishmaniasis |
| 02/03/1994 | WO1994002152A2 Phosphono derivatives as antiinflammatory and antiarthritic agents |
| 02/03/1994 | WO1994002151A1 TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING THE ACTIVE SUBSTANCE 17-β-OESTRADIOL (ANHYDROUS) |
| 02/03/1994 | WO1994002150A1 Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity |
| 02/03/1994 | WO1994002148A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | WO1994002147A1 Water-dispersible tablets |
| 02/03/1994 | WO1994002146A1 Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
| 02/03/1994 | WO1994002144A1 Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris |
| 02/03/1994 | WO1994002143A1 Use of 3-phenoxypyridine in the treatment of psychomotor stimulant addiction |
| 02/03/1994 | WO1994002142A1 Substituted biphenylmethylimidazopyridines |
| 02/03/1994 | WO1994002141A1 Injection and injection kit containing omeprazole and its analogs |
| 02/03/1994 | WO1994002140A1 Pharmaceutical composition containing antiulcer agent |
| 02/03/1994 | WO1994002139A1 Composition and methods for decreasing muscle breakdown |
| 02/03/1994 | WO1994002138A1 Pharmaceutical composition and method of treatment for serotonin depletion illness |
| 02/03/1994 | WO1994002137A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002136A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002135A1 Therapeutic process for the treatment of septic shock |
| 02/03/1994 | WO1994002133A1 Treatment of burns |